Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (1): 15-21.doi: 10.13481/j.1671-587X.20230103
• Research in basic medicine • Previous Articles Next Articles
Fuqiang XUE1,Rongjian SU2,Wubin HE2,Huijuan SONG2,Zhidong LUAN1(
)
Received:2022-03-17
Online:2023-01-28
Published:2023-02-03
Contact:
Zhidong LUAN
E-mail:3286601700@qq.com
CLC Number:
Fuqiang XUE,Rongjian SU,Wubin HE,Huijuan SONG,Zhidong LUAN. Regulatory effect of ring finger protein 31 on expression of epidermal growth factor receptor and its mechanism[J].Journal of Jilin University(Medicine Edition), 2023, 49(1): 15-21.
| 1 | ROBICHAUX J P, LE X N, VIJAYAN R S K, et al. Structure-based classification predicts drug response in EGFR-mutant NSCLC[J]. Nature, 2021, 597(7878): 732-737. |
| 2 | KOHNO T, MATSUI T, ENATSU S. Differences between EGFR exon 19 deletion and exon 21 L858R point mutation, frequently detected EGFR mutations in patients with non-small cell lung cancer, from a molecular biology viewpoint[J]. Gan To Kagaku Ryoho, 2021, 48(12): 1463-1467. |
| 3 | SIGISMUND S, AVANZATO D, LANZETTI L. Emerging functions of the EGFR in cancer[J]. Mol Oncol, 2018, 12(1): 3-20. |
| 4 | NGUYEN P V, ALLARD-VANNIER E, CHOURPA I,et al. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: biological strategy, design and quality control[J]. Int J Pharm, 2021, 605: 120795. |
| 5 | URIBE M L, MARROCCO I, YARDEN Y. EGFR in cancer: signaling mechanisms, drugs, and acquired resistance[J]. Cancers, 2021, 13(11): 2748. |
| 6 | LEE Y J, HO S R, GRAVES J D, et al. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer[J]. Breast Cancer Res, 2019, 21(1): 134. |
| 7 | VAUGHAN R M, KUPAI A, ROTHBART S B. Chromatin regulation through ubiquitin and ubiquitin-like histone modifications[J]. Trends Biochem Sci, 2021, 46(4): 258-269. |
| 8 | DAMGAARD R B. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities[J].Cell Death Differ,2021,28(2):423-426. |
| 9 | RODRIGUEZ CARVAJAL A, GRISHKOVSKAYA I, GOMEZ DIAZ C, et al. The linear ubiquitin chain assembly complex (LUBAC) generates heterotypic ubiquitin chains[J]. Elife, 2021, 10: e60660. |
| 10 | LIU J P, WANG Y L, GONG Y K, et al. Structural insights into SHARPIN-mediated activation of HOIP for the linear ubiquitin chain assembly[J]. Cell Rep, 2017, 21(1): 27-36. |
| 11 | DRABER P, KUPKA S, REICHERT M, et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes[J]. Cell Rep, 2015, 13(10): 2258-2272. |
| 12 | JIMBO K, KOIDE S, ITO T, et al. Deficiency of the E3 ligase hoip impairs adult hematopoiesis and myeloid leukemia[J]. Blood, 2021, 138: 1153. |
| 13 | ELLIOTT P R, LESKE D, HRDINKA M, et al. SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling[J].Mol Cell,2016,63(6): 990-1005. |
| 14 | TAKIUCHI T, NAKAGAWA T, TAMIYA H, et al. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN[J]. Genes Cells, 2014, 19(3): 254-272. |
| 15 | SCHAEFFER V, AKUTSU M, OLMA M H, et al. Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling[J]. Mol Cell, 2014, 54(3): 349-361. |
| 16 | DOUGLAS T, SALEH M. The plot thickens: OTULIN regulation in cell death[J]. Mol Cell Oncol, 2020, 7(4): 1740541. |
| 17 | RITTINGER K, IKEDA F. Linear ubiquitin chains: enzymes, mechanisms and biology[J]. Open Biol, 2017, 7(4): 170026. |
| 18 | BURNETT H, EMICH H, CARROLL C, et al. Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: a systematic literature review[J].PLoS One,2021,16(3): e0247620. |
| 19 | PONSIOEN B, POST J B, BUISSANT DES AMORIE J R, et al. Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling[J]. Nat Cell Biol, 2021, 23(4): 377-390. |
| 20 | JIANG Y H, LIM J, WU K C, et al. PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR[J]. Br J Pharmacol, 2021, 178(4): 913-932. |
| 21 | LI T, TAO Z H, ZHU Y H, et al. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer[J].Cell Death Dis,2021,12(7): 684. |
| 22 | CHEN N, HAN X D, YIN B, et al. FGD5 facilitates tumor growth by regulating EGFR ubiquitination in gastric cancer[J]. Biochem Biophys Res Commun, 2021, 562: 43-49. |
| 23 | LI S, ZHENG X M, HU Y C, et al. RNF31 mediated ubiquitination of A20 aggravates inflammation and hepatocyte apoptosis through the TLR4/MyD88/NF-κB signaling pathway[J]. Chem Biol Interact, 2021, 348: 109623. |
| 24 | ZHU J, ZHAO C, KHARMAN-BIZ A, et al. Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation[J]. Oncogene, 2019, 38(2): 299-300. |
| 25 | NIU Z G, LI X, DONG S X, et al. The E3 ubiquitin ligase HOIP inhibits cancer cell apoptosis via modulating PTEN stability[J]. J Cancer, 2021, 12(21):6553-6562. |
| 26 | ELLIOTT P R, NIELSEN S V, MARCO-CASANOVA P, et al. Molecular basis and regulation of OTULIN-LUBAC interaction[J].Mol Cell, 2014, 54(3): 335-348. |
| 27 | STANGL A, ELLIOTT P R, PINTO-FERNANDEZ A,et al. Regulation of the endosomal SNX27-retromer by OTULIN[J]. Nat Commun, 2019, 10(1): 4320. |
| [1] | Like LUO,Ziwen CHENG,Kuo CHENG,Yonggang LI,Dawei WANG,Baoling YANG. Expression and localization of fever with thrombocytopenia syndrome virus nonstructural protein and screening and analysis of host-interacting proteins [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1286-1296. |
| [2] | Lyuyin SUN,Zhuping MA,Runlin LI,Yonggang LI,Xiaoli TAO. Screening of host proteins interacting with Nelson Bay orthoreovirus σNS based on yeast two-hybrid technology [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1313-1321. |
| [3] | Haiyao PANG,Jun MENG. Research progress in relationship between 14-3-3ɛ protein and occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 572-578. |
| [4] | Yang YU,Dan TIAN,Donghe NI,Duo ZHANG. Network pharmacologry and molecular docking analysis based on mechanism of monk fruit in treatment of diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 161-167. |
| [5] | Tengfei LI,Shiyu WANG,Xinru JIANG,Miao SUN,Tingting LI,Jiafeng LIN,Ying WANG,Yonggang LI,Xiaoli TAO. Analysis on expression characteristics of non-structural protein μNS and σNS of Nelson Bay orthoreovirus [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 934-942. |
| [6] | Qin WANG, Chunlin LIN, Zhibin CHENG, Ruofan HE, Penghang LIN, Hui CHEN, Jianxin YE, Guangwei ZHU. Construction of TRAF6 ubiquitination site mutation vectors and identification of its functional ubiquitination sites [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 551-558. |
| [7] | Lijuan HA,Fuchun WANG,Xiaona LIU. Intervention effects of single acupoint and acupoint compatibility in gastric ulcer rats and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1131-1136. |
| [8] | LI Cheng, LIU Hui, GUO Liang, MA Yunfei, LIU Bailong, DONG Lihua. Radiotherapy combined with gefitinib in treatment of low-grade pulmonary mucoepidermoid carcinoma with EGFR sensitive mutation: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1436-1439. |
| [9] | ZHOU Hongxu, DU Ye, YU Yunhe, HAN Bing, LI Sijie, GUO Guoqiang, FAN Zhimin. Discordance for hormone receptors and Her-2 expressions in primary lesion and ipsilateral axillary lymph node metastasis of breast cancer and its influence in prognosis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 376-382. |
| [10] | ZHENG Fang, OUYANG Zhengren, OUYANG Jinglin, ZHOU Shili, LUO Wen. Analysis on correlations between ultrasound features and positive expressions of CerbB-2and Ki-67 in patients with breast cancer [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1073-1077. |
| [11] | YU Xiuyan, ZHANG Xiaowei, YE Lili, LI Ting, LIU Xiaofeng, WU Xuefeng. Application of detection of expressions of hMAM combined with MMP-9 and C-erbB2 mRNA in peripheral blood in diagnosis of micrometastases of breast cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1009-1014. |
| [12] | LIU Xiangliang, JI Wei, LI Li, ZHAO Yinghua, JIA Lin, WANG Zhiqiang, CHEN Xiao, LI Wei. Lung adenocarcinoma treated by Erlotinib HCL Tablets and chemotherapy combined with bevacizumab after drug resistance:A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1019-1024. |
| [13] | LI Haobo, DU Yong, CHEN Yong, LI Wenjing. Influence of Notch 1 in expression of EGFR in tongue squamous cell carcinoma Tca8113 cells [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 715-719. |
| [14] | LIU Chao, REN Lili, LUAN Zhidong, MENG Zhichao, LIU Yimeng, XIAO Jianying. Screening of candidate molecules interacting with protein kinase Wee1B from human ovary cDNA library and its regulation effect [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 866-871. |
| [15] | ZHANG Min, CUI Yunqin, SONG Huanfang, LYU Jianyi, XU Xiaohong, GAO Jimin. Influence of EGFR in B[a]P-induced SIRT1 activation in human bronchial epithelial cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 731-736. |
|